The Injective white paper reshapes the INJ chain and focuses on tokenized finance. At the heart of this news is on-chain credit. On-chain credit will affect the on-chain of traditional financial assets, risk control efficiency and the pace of institutional capital entry. Do you think it will have a real impact, or is it more of a short-term sentiment?